Imaging agent developer ImaginAb has launched ImaginAb Japan, a wholly owned subsidiary headquartered in Tokyo.
Dr. Shintaro Nishimura will serve as the subsidiary's executive director. Nishimura most recently was vice president of bioimaging research laboratories at Astellas Pharma.
ImaginAb's product portfolio includes imaging agents for prostate, pancreatic, and ovarian cancers. The company sees Japan as a major market for PET imaging.
